Cargando…

Inactivated vaccine for SARS-CoV-2

Detalles Bibliográficos
Autor principal: Risson, Emma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192055/
https://www.ncbi.nlm.nih.gov/pubmed/32355330
http://dx.doi.org/10.1038/s41577-020-0334-1
_version_ 1783527951986327552
author Risson, Emma
author_facet Risson, Emma
author_sort Risson, Emma
collection PubMed
description
format Online
Article
Text
id pubmed-7192055
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-71920552020-04-30 Inactivated vaccine for SARS-CoV-2 Risson, Emma Nat Rev Immunol In Brief Nature Publishing Group UK 2020-04-30 2020 /pmc/articles/PMC7192055/ /pubmed/32355330 http://dx.doi.org/10.1038/s41577-020-0334-1 Text en © Springer Nature Limited 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle In Brief
Risson, Emma
Inactivated vaccine for SARS-CoV-2
title Inactivated vaccine for SARS-CoV-2
title_full Inactivated vaccine for SARS-CoV-2
title_fullStr Inactivated vaccine for SARS-CoV-2
title_full_unstemmed Inactivated vaccine for SARS-CoV-2
title_short Inactivated vaccine for SARS-CoV-2
title_sort inactivated vaccine for sars-cov-2
topic In Brief
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192055/
https://www.ncbi.nlm.nih.gov/pubmed/32355330
http://dx.doi.org/10.1038/s41577-020-0334-1
work_keys_str_mv AT rissonemma inactivatedvaccineforsarscov2